RCT Comparing OAGB and Long Limb Roux Gastric Bypass
Launched by TARTU UNIVERSITY HOSPITAL · Mar 21, 2021
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two types of weight-loss surgeries: one-anastomosis gastric bypass (OAGB) and long biliary limb Roux gastric bypass. The goal is to see how these surgeries help patients lose weight and improve related health conditions, such as type 2 diabetes, high blood pressure, high cholesterol, and sleep apnea. The study will involve up to 500 patients from three clinics in Estonia, and participants will be followed for up to ten years after their surgery to assess their progress and overall quality of life.
To be eligible for this trial, participants should be between 18 and 60 years old and have a body mass index (BMI) over 35 with related health issues, or a BMI over 40. Those who are younger than 18 or older than 60, have had previous weight-loss surgeries, or have certain medical conditions may not be able to participate. If you choose to take part, you can expect regular check-ups at one, five, and ten years post-surgery to monitor your health and any nutritional needs. This trial is unique because it specifically compares these two types of gastric bypass surgeries, which hasn't been done before.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI over 35 and obesity related disease
- • BMI over 40
- • age between 18-60 years
- • agrees to participate in the study
- Exclusion Criteria:
- • age under 18 years or over 60 years
- • abundant adhesions discovered during the surgery
- • active upper gastrointestinal ulcer disease
- • prior bariatric surgery
- • active symptomatic reflux disease
- • active psychiatric disease (eg psychosis)
About Tartu University Hospital
Tartu University Hospital is a leading academic medical center in Estonia, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a sponsor of clinical studies, the hospital leverages its extensive expertise in various medical fields, fostering collaboration between researchers, healthcare professionals, and patients. With a focus on improving patient outcomes and contributing to the global medical community, Tartu University Hospital is dedicated to conducting rigorous and ethically sound clinical research that addresses critical health challenges. Its state-of-the-art facilities and multidisciplinary approach enable the exploration of new therapies and treatment modalities, positioning it at the forefront of medical advancement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tartu, , Estonia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials